5: Opioid Risk Assessment, Mitigation, and Management

Credit Available: CE Credit(s): No
Designations: Certificate of Attendance, 1-hour

*Note: These presenters were Involved in the development of the 2017 Curriculum only.

Cost: No fee

Target Audience: This activity is designed for physicians, nurse practitioners or other advanced practice nurses, and PAs. This activity is not accredited.

Description: This activity focuses on the assessment, mitigation and management of opioid risk. Learners are introduced to information on universal precautions and their role in opioid therapy, and monitoring and documentation strategies. The fundamental principles of urine drug testing and interpretation are reviewed, as well as the differential diagnosis for drug misuse. Naloxone and when it should be co-prescribed are also discussed.

Educational Objectives:

  • Describe universal precautions and their role in opioid therapy
  • Review monitoring and documentation strategies for opioid therapy
  • Explain the fundamental principles of urine drug testing and interpretation
  • List the differential diagnosis for drug misuse
  • Describe when naloxone co-prescription should be considered
Kenneth Stoller, MD, 2018 Steering Committee Meeting

Didn't find what you were looking for?